| | Press release |
Procedures for obtaining preparatory documents for the shareholders' annual general meeting (ordinary and extraordinary) of 12 May 2017
Boulogne-Billancourt, 5 April 2017 - Vallourec's Ordinary and Extraordinary Shareholders' Meeting will be held on Friday 12 May 2017 at 10:00 a.m. at the Maison de la Mutualité - 24, rue Saint-Victor - 75005 Paris.
The preliminary notice of meeting published in the Bulletin des Annonces Légales Obligatoires of 5 April 2017 and the notice of meeting brochure including the agenda, draft resolutions and reports of the Management Board and the Supervisory Board thereon as well as the procedures for participating in the Meeting and voting are available on Vallourec's website (www.vallourec.com: Group > Finance > General meetings > 2017).
The information referred to in Articles R.225-81 and R.225-83 of the French Code de commerce is included in the notice of meeting brochure, as well as in the 2016 Registration Document, each of which is available on Vallourec's website (www.vallourec.com : Group > Finance > General meetings > 2017).
The other documents and information about the Shareholders' Meeting will be available to shareholders, in accordance with the prevailing regulations, at Vallourec's registered office at 27, avenue du Général Leclerc, 92100 Boulogne-Billancourt.
About Vallourec
Vallourec is a world leader in premium tubular solutions for the energy markets and for demanding industrial applications such as oil & gas wells in harsh environments, new generation power plants, challenging architectural projects, and high-performance mechanical equipment. Vallourec's pioneering spirit and cutting-edge R&D open new technological frontiers. With close to 19,000 dedicated and passionate employees in more than 20 countries, Vallourec works hand-in-hand with its customers to offer more than just tubes: Vallourec delivers innovative, safe, competitive and smart tubular solutions, to make every project possible.
Listed on Euronext in Paris (ISIN code: FR0000120354, Ticker VK) and eligible for the Deferred Settlement System (SRD), Vallourec is included in the following indices: SBF 120 and Next 150.
In the United States, Vallourec has established a sponsored Level 1 American Depositary Receipt (ADR) program (ISIN code: US92023R2094, Ticker: VLOWY). Parity between ADR and a Vallourec ordinary share has been set at 5:1.
vallourec.com
Follow us on Twitter @Vallourec
For further information, please contact:
| Investor Relations Etienne Bertrand Tel: +33 (0)1 49 09 35 58 [email protected] | Press Relations Héloïse Rothenbühler Tel: +33 (0)1 41 03 77 50 / +33 (0)6 45 45 19 67 [email protected] |
| Guilherme Camara Tel: +33 (0)1 49 09 39 92 [email protected] | Individual Shareholder Toll free Number (from France): 0 800 505 110 [email protected] |
Attachments:
http://www.globenewswire.com/NewsRoom/AttachmentNg/aa90b769-80f0-4611-a2be-d508bfcb25b1


Instagram Outage Disrupts Thousands of U.S. Users
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
Washington Post Publisher Will Lewis Steps Down After Layoffs
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing 



